Steven Glazer
InvestorPartner at Ventac Partners
Copenhagen, Denmark
Writes $100K – $5M checks · typically $1.5M
Find your path to Steven
222 people in our graph share verified history with Steven — schools, employers, funds. One of them is your warm intro.
Jesper GromadaunlockedSteven: together at Novo Nordisk (1995)
Steven: together at Maxygen
×9Steven: together at Københavns Universitet - University of Copenhagen
Steven: together at Novo Nordisk
About
Steven Glazer is a drug development consultant at Glazer Consulting APS with experience in healthcare and biotech sectors. He has held senior and operational roles in pharmaceutical, biopharmaceutical, biotechnology, and diagnostic companies across Europe and the United States, with expertise in research and development, medical affairs, and regulatory affairs.
Experience
- Glazer Consulting APSDrug Development Consultantcurrent2012 — presentCopenhagen Metropolitan Area
- Monta BioSciencesChief Medical Officercurrent2020 — presentCopenhagen, Capital Region, Denmark
- Ventac PartnersPartnercurrent2019 — presentCopenhagen Area, Capital Region, Denmark
- Allero TherapeuticsChief Medical Officer2020 — 2022Rotterdam, Netherlands
- RhoVacMedical Director2018 — 2022Copenhagen Area, Denmark
- Immunicum AB (IMMU)Board Member and Chair of Scientific Board2016 — 2021Gothenburg, Sweden
- Idogen ABChief Medical Officer2017 — 2019Lund, Sweden
- Hansa MedicalChief Medical Officer2015 — 2017Lund, Sweden
- BioInvent International ABSVP Development2004 — 2012
- MaxygenDirector Development2001 — 2004
- Zealand PharmaVice President Development2000 — 2001
- Sunol MolecularVP Clinical and Regulatory Affairs1998 — 2000
- Dade BehringClinical Director1996 — 1998
- Novo Nordisk A/SMedical Director1987 — 1995
Skills & more
Oncology Clinical ResearchSystem Implementations1Stakeholder Management1Business Process Improvement1Product Development1Problem Solving1Identifying IssuesCommunicationAnalytical SkillsClinical Development30Biotechnology25Drug Development20
+12 more
Regulatory AffairsFDAOncologyBiopharmaceuticalsMedical AffairsPharmaceutical IndustryLife SciencesClinical TrialsMedical DevicesLifesciencesClinical ResearchMonoclonal AntibodiesLanguages Danish · English
From Steven's professional profile.
Colleagues at Ventac Partners
Carlton Anderson
Partner at Ventac Partners
Dede Willis
Partner at Ventac Partners
Dennis Henriksen
Partner at Ventac Partners
Kostas Alevizopoulos
Partner at Ventac Partners
Lars Hedbys
Partner at Ventac Partners
Lasse Richter Petersen
Partner at Ventac Partners
Mikael Ørum
Partner at Ventac Partners
Neil Thomas
Partner at Ventac Partners
Frequently asked questions
- Who is Steven Glazer?
- Steven Glazer is a drug development consultant at Glazer Consulting APS with experience in healthcare and biotech sectors. He has held senior and operational roles in pharmaceutical, biopharmaceutical, biotechnology, and diagnostic companies across Europe and the United States, with expertise in research and development, medical affairs, and regulatory affairs.
- Where does Steven Glazer work?
- Steven Glazer is Partner at Ventac Partners.
- What check size does Steven Glazer write?
- Steven Glazer typically writes checks of $100K – $5M.
- Where did Steven Glazer go to school?
- Steven Glazer studied at Københavns Universitet - University of Copenhagen (Doctor of Medicine (MD)).
Same school
Also attended Københavns Universitet - University of Copenhagen181
David HelgasonUnity co-founder; Partner at TransitionJesper GromadaInvestor at Third Rock VenturesUlrik B. NielsenGeneral Partner at Mission BiocapitalTommy AhlersFormer Danish Science Minister at Giant Ventures Global LlpTaro HizumeGeneral Partner at Ff Venture CapitalClaus AnderssonGeneral Partner at Sunstone Capital
+ 175 more
Shared employers
Also worked at Allero Therapeutics2
Also worked at RhoVac4
Also worked at Maxygen6
Jamie BacherEntrepreneur-In-Residence at The Innovation SpaceRuchita SinhaGeneral Partner at AV8 VenturesJosh SilvermanInvestor at Baruch Future VenturesGjalt HuismanInvestor at Baruch Future VenturesJan Møller MikkelsenPresident at Ascendis Pharma A/SFrances H. ArnoldVenture Partner at Catalio Capital Management, LP
